Form D Explorer

Inspect source fieldsReport a record issue

Form D — RenovoRx, Inc.

0001465818-26-000003 · filed Apr 9, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$10,000,000
Reported amount sold
$9,999,929
Minimum investment
$10,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
RenovoRx, Inc.
CIK
1574094
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
2570 W EL CAMINO REAL, SUITE 320
MOUNTAIN VIEW, California 94040
Phone
650-284-4433

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗